New Clinical Trial Starts at Boston Neuropsychiatry

Posted on February 4, 2021February 4, 2021 by bostonneuropsychiatry_3225db

Site Initiation Occurred for New Alzheimer Disease Trial

The primary purpose of this study is to evaluate the effect of a new medication versus placebo on cognitive decline using the Alzheimer’s Disease Assessment Scale Cognitive subscale 13‑item version (ADAS-Cog13). Contact us to learn more.

Site Set Up

Posted on January 19, 2021February 4, 2021 by bostonneuropsychiatry_3225db

Multicenter Clinical Trial Site Set Up

desktop

LOCATION: 44 Adams Street #4, Braintree MA 02184 USA

Site set up at 44 Adams St location. Multicenter trials are conducted out of several locations in: United States, Japan, Canada, Australia, Spain, Belgium, Netherlands, France, Sweden

News From Boston Neuropsychiatry Center

Posted on January 19, 2021February 4, 2021 by bostonneuropsychiatry_3225db

Participants with Early Alzheimer’s Disease

laptop

If you’re a caregiver considering joining a clinical trial, you’ll want to have a plan beforehand. Planning your visits ahead will help your loved one remain consistent over time. It’ll also help you determine whether or not there’s enough time to maintain the increasing demands of dementia. Read more >